Atlas Trials

Antagonism of Neostigmine in Continuous Infusion of Mivacurium

Clinical trial NCT07524959 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07524959
Sponsor
Beijing Tongren Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Neuromuscular Blocking Agents
Start date
2026-05-01
Primary completion
2026-07-20
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.